Who Said It Better? A Test of Wording Differences in the MedWatch "Toll-Free Statement" for Consumer Reporting of Side Effects in Direct-to-Consumer Television Advertisements

Conclusions:
Findings suggest that the FDAAA toll-free statement wording is superior to that of the TFNR.

Source: Therapeutic Innovation and Regulatory Science - February 22, 2016 Category: Drugs & Pharmacology Authors: Aikin, K. J., ODonoghue, A. C., Sullivan, H. W., Betts, K. R., Squire, C. Tags: Product Safety Source Type: research